Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

CX Venture Group



Unlock datapoints

Portfolio analytics


News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
The average size of a deal this fund participated in
Rounds per year 0.03
Lead investments 0
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment


CX Venture Group is the famous VC, which was founded in 1990. The leading representative office of defined VC is situated in the Taipei. The company was established in Asia in Taiwan.

The important activity for fund was in 2005. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Among the most successful fund investment fields, there are Therapeutics, Biotechnology. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Cellerant Therapeutics

The typical case for the fund is to invest in rounds with 5 participants. Despite the CX Venture Group, startups are often financed by MPM Capital, Allen & Company. The meaningful sponsors for the fund in investment in the same round are Novel Bioventures, MPM Capital, George Rathmann. In the next rounds fund is usually obtained by MPM Capital, Camelot Venture Group.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
ARIA Fund Mazowieckie, Poland, Warszawa
Chinese Media China, Guangdong, Jiangxi
CVSHealth Rhode Island, United States, Woonsocket
Cycle Venture Partners -
Deloitte Tohmatsu Capital Japan, Tokyo
Formative Ventures California, Santa Clara, United States
Impres Health -
Langfang Wuxian Beijing, China, Tongzhou
LEGO Brand Group -
Medalist Capital Charlotte, North Carolina, United States
New Life Ventures -
NewGaoQiao E-Business China, Fujian, Hunan
Owl Ventures California, San Francisco, United States
Ricoh Company Japan, Tokyo
Salt Lake Life Science Angels Salt Lake City, United States, Utah
Telluric Foods -
Terra Rossa Capital Adelaide, Australia, South Australia
The Libra Foundation California, San Francisco, United States
The Luxury Fund -
VIMAC Milestone Medical Fund -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cellerant Therapeutics

Clinical Trials
$16M11 May 2005 California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CX Venture Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 16M
Rounds per year 0.03
Peak activity year 2005
Lead investments 0

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cellerant Therapeutics

Clinical Trials
$16M11 May 2005 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: